Shareholder Rights Advocates at Levi & Korsinsky Investigate ADMA Biologics, Inc. (ADMA) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / October 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ:ADMA) concerning possible violations of federal securities laws. On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. The news […]